About >> Papers & Publications

Peer Reviewed Journal Publications

M R Feneley, M Schoenberg. Bladder Sparing Strategies for Transitional Cell Carcinoma. Editorial. Urology (2000), 56 (4), 549-60.
M R Feneley, M Schoenberg. Bladder Sparing Strategies for Transitional Cell Carcinoma. Editorial. Urology (2000), 56 (4), 549-60.
M R Feneley, J K Mellon. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer. Review article. Seminars in Urologic Oncology (2000), 18(4), 300-7.
M R Feneley, A W Partin. Diagnosis of localized prostate cancer: 10 years of progress. Current Opinion in Urology (2000), 10 (4), 319-27.
M R Feneley, P Landis, I Simon, E J Metter, C H Morrell, H B Carter, P C Walsh. Today men with prostate cancer have larger prostates. Urology. (2000), 56 (5), 839-42.
M R Feneley, H Jan, M Granowska, S J Mather, D Ellison, J Glass, M Coptcoat, R S Kirby, C Ogden, R T D Oliver, D F Badenoch, F I Chinegwundoh, V H Nargund, A M I Paris and K E Britton. Imaging with Prostate Membrane-Specific Antigen (PMSA) in Prostate Cancer. Prostate Cancer and Prostatic Diseases, (2000), 3, 47-52.
M R Feneley, R C L Feneley. Funding research in urological training: the need for a future strategy and longer term strategies. Annals of the Royal College of Surgeons of England (1999), 81, 145-150.
P N Span, M C W Voller, A G H Smals, F G J Sweep, J A Schalken, M R Feneley and R S Kirby. Selectivity of Finasteride as in vivo inhibitor of 5-alpha reductase isozyme enzymatic activity in human prostate. Journal of Urology (1999), 161, 332-337.
M R Feneley. Does screening for prostate cancer identify clinically important disease? Annals of the Royal College of Surgeons of England (1999), 81, 207-214.
M R Feneley and P C Walsh. Incontinence after radical prostatectomy. Lancet (1999), 353, 2091-2092.
M R Feneley. Electrovaporisation of the prostate. Lancet (1998), 351, 999-1001.
M R Feneley, P Span, J Schalken, M Harper, K Griffiths and R S Kirby. Tissue effects of finasteride in patients with benign prostatic hyperplasia: a controlled, randomised study. Prostate Cancer and Prostatic Diseases, (1999), 2, 227-281.
M R Feneley and R C L Feneley. The contribution of research to urological training in the United Kingdom. British Journal of Urology (1998), 81, 193-198.
M R Feneley, C Busch. Precursor lesions for prostate cancer and their clinical significance. Review Editorial. Journal of the Royal Society of Medicine (1997), 90, 533-539.
K E Britton, M R Feneley, H Jan, V U Chengazi, M Granowska. Prostate Cancer: the contribution of nuclear medicine. BJU Int (2000), Suppl 1, 135-42.
M E Laniado and M R Feneley. Urologists on the Internet: practical applications are now a reality. British Journal of Urology (1997), 80 (Suppl 3), 12-15.
M R Feneley, R S Kirby. Screening for prostate cancer: can it be justified? Journal of Managed Care (1997), 1, 61-66.
M R Feneley, J S A Green, P Bose, M P Young, W B Peeling, R S Kirby, M C Parkinson. The prevalence of prostatic intra-epithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implications. Prostatic Cancer and Prostatic Diseases (1997), 1, 79-83.
M R Feneley, M K Pal, I Nockler, W F Hendry. Varicocele embolisation versus ligation: venographic findings and causes of failure. British Journal of Urology (1997), 80, 642-6.
V U Chengazi, M R Feneley, D Ellison, C C Nimmon, M Salteri, S J Mather, M Granowska, A Granowski, R S Kirby, K E Britton. Imaging prostate cancer with technetium-99m-7E11-C5.3. The Journal of Nuclear Medicine (1997), 38, 675-682.